Liability and Efficacy From Long-Term Use of Benzodiazepines: Documentation and Interpretation
1995; Slack Incorporated (United States); Volume: 25; Issue: 3 Linguagem: Inglês
10.3928/0048-5713-19950301-10
ISSN1938-2456
Autores Tópico(s)Treatment of Major Depression
ResumoBENZODIAZEPINES: EFFICACY AND LIABILITYLiability and Efficacy From Long-Term Use of Benzodiazepines: Documentation and Interpretation Norman S Miller, MD, , MD Norman S Miller, MD Psychiatric Annals, 2013;25(3):166–173Published Online:March 01, 1995https://doi.org/10.3928/0048-5713-19950301-10Cited by:7View Full TextPDF ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinkedInRedditEmail SectionsMore1. Miller NS, Gold MS. Introduction. Benzodiazepines: a major problem. J Subst Abuse Treat. 1991; 8:3-7. > Google Scholar2. Rickeis K, Schweizer E, Case G, Greenblatt DJ. Longterm therapeutic use of benzodiazepines, I: effects of abrupt discontinuation. Arch Gen Psychiatry. 1990; 47:899-907. > Google Scholar3. Schweizer E, Rickeis K, Case G, Greenblatt DJ. Longterm therapeutic use of benzodiazepines, II: effects of gradual taper. Arch Gen Psychiatry. 1990; 47:908-915. > Google Scholar4. Schweizer E, Rickels K, Weiss S, Zavodnick S. Maintenance drug treatment of panic disorder, I: results of a prospective, placebo-controlled comparison of alprazolam and imipramine. Arch Gen Psychiatry. 1993; 50:51-60. > Google Scholar5. Rickels K, Schweizer E, Weiss S, Zavodnick S. Maintenance drug treatment for panic disorder, II: short- and long-term outcome after drug taper. Arch Gen Psychiatry. 1993; 50:61-68. > Google Scholar6. Miller NS, Mahler JC. Addiction to and dependence on benzodiazepines. J Subst Abuse Treat. 1991; 8:61-67. > Google Scholar7. Ashton H. Toxicity and adverse consequences of benzodiazepine use. Psychiatric Annals. 1995; 25:158-165. > Google Scholar8. Allgulander C, Ljungberg L, Fisher LD. Long-term prognosis in addiction on sedative and hypnotic drugs analyzed with the Cox regression model. Acta Psychiatr Scand. 1987; 75:521-531. > Google Scholar9. Woods JH, Katz JL, Winger G. Abuse liability of benzodiazepines. Pharmacol Rev. 1987; 39:251-413. > Google Scholar10. Cappell HD, Sellars EM, Busto U. Benzodiazepines as drugs of abuse and dependence. In: Cappell HD, Glaser FB, Israel Y, et al. Recent Advances in Alcohol and Drug Problems. New York: Plenum Press, 1986:53-126. > Google Scholar11. Ciraulo DA, Sands BF, Shader RI. Critical review of liability for benzodiazepine abuse among alcoholics. Am J Psychiatry. 1988; 145:1501-1506. > Google Scholar12. DuPontRL, ed. Abuse of benzodiazepines: the problems and the solutions: a report of a committee of the Institute for Behavior and Health Inc. A?n J Drug Alcohol Abuse. 1988; 14(suppl 1):1-69. > Google Scholar13. Noyes R, DuPont RL, Pecknold JC, et al. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial, II; patient acceptance, side effects and safety. Arch Gen Psychiatry. 1988; 49:382-388. > Google Scholar14. Marks IM, DeAlbuquerque A, Cottreaux J, et al. The 'efficacy' of alprazolam in panic disorder and agoraphobia: a critique of recent reports. Arch Gen Psychiatry. 1989; 46:668-670. Letter. > Google Scholar15. Pecknold JC, Swinson RP, Kuck K, Lewis CP. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial, III: discontinuation effects. Arch Gen Psychiatry. 1988; 45:429-436. > Google Scholar16. Busto V, Simpkins J, Sellars EM. Objective determination of benzodiazepine abuse and dependence. British Journal of Addiction. 1986; 81:87-94. > Google Scholar17. Busto U, Sellars EM, Naranjo CA, Cappell HD, Sanchez-Craig M, Sykora K. Withdrawal reaction after long-term therapeutic use of benzodiazepines. N Engl J Med. 1986; 315:854-859. > Google Scholar18. Griffiths RR, McLeod DR, Bigelow GE, Liebson IA, Roache JD, Nowowieski P. Comparison of diazepam and oxazepam: preference, liking and extent of abuse. J Pharmacol Exp Ther. 1984; 229:501-508. > Google Scholar19. Griffiths RR, Roache JD. Abuse liability of benzodiazepines: a review of human studies evaluating subjective and/or reinforcing effects. In: Smith DE, Wesson DR, eds. The Benzodiazepines: Current Standards for Medical Practice. Lancaster, England: MTP Press Ltd; 1985:209-225. > Google Scholar20. Griffiths RR, Sannerud CA, Abuse and dependence on benzodiazepines and other anxiolytic/sedative drugs. In: Meltzer HY, ed. Psychopharmacology, the. Third Generation of Progress. New York: Raven Press; 1987:1535-1541. > Google Scholar21. Rickels K, Case WG, Schweizer EE, Swenson C, Fridman RB. Low dose dependence in benzodiazepine users: a preliminary report on 119 patients. Psychopharmacol Bull. 1986; 22:407-415. > Google Scholar22. Ladewig D. Banzinger W, Lowenheck M. Tranquilizer abuse - results of a nationwide Swiss survey. Journal of Drug Research (TNO). 1981; 6:1131-1137. > Google Scholar23. Ladewig D. Abuse of benzodiazepines in Western European society - incidence, prevalence, motives, drug acquisition. Pharm.acopsychiatry. 1983; 16:103-106. > Google Scholar24. Roy-Byrne PP, Hammer D. Benzodiazepine withdrawal: overview and implications for the treatment of anxiety. Am J Med. 1988; 84:1041-1052. > Google Scholar25. Roy-Byrne PP, Dager SR, Cowley DS, Vitaliano P, Dunner DL. Relapse and rebound following discontinuation of benzodiazepine treatment in panic attacks: alprazolam versus diazepam. Am J Psychiatry. 1989; 146:860-865. > Google Scholar26. Busto U, Sellers EM. Pharmacologie aspects of benzodiazepine tolerance and dependence. J Subst Abuse Treat. 1991; 8:29-33. > Google Scholar27. Juergens S. Alprazolam and diazepam: addiction potential. J Subst Abuse Treat. 1991; 8:43-51. > Google Scholar28. deWit H, McCracken SM, Uhlenhuth EH, Johansen CE. Diazepam preference in subjects seeking treatment for anxiety. NIDA Research Monograph Series. 1987; 76:248-254. > Google Scholar29. Ciraulo DA, Barnhill JG, Greenblatt DJ, et al. Abuse liability and clinical pharmacokinetics of alprazolam in alcoholic men. J Clin Psychiatry. 1988; 49:333-337. > Google Scholar30. McCracken SG, deWit H, Uhlenhuth EH, Johanson CE. Preference for diazepam in anxious adults. J Clin Psychopharmacol. 1990; 10:190-196. > Google Scholar31. Hartog J, Tusol DJ. Valium use and abuse by methadone maintenance clients. Int J Addict. 1987; 22:11471154. > Google Scholar32. Smith DE, Wesson DR. Benzodiazepine dependency syndromes. J Psychoactiue Drugs. 1983; 15(1-2):85-95. > Google Scholar33. Miller NS, Gold MS, Stennie K. Benzodiazepines: the dissociation of addiction from pharmacological dependence/withdrawal. Psychiatric Annals. 1995; 25:149-152. > Google Scholar34. Busto V, Simpkins J, Sellars EM. Objective determination of benzodiazepine use and abuse in alcoholics. British Journal of Addiction. 1983; 78:429-435. > Google Scholar35. Busto U, Sellars EM, Naranjo CA, Cappell H, SanchezCraig M, Sykora K. Withdrawal reaction after longterm therapeutic use of benzodiazepines. N Engl J Med. 1986; 144:303-308. > Google Scholar36. Owen RT, Tyrer P. Benzodiazepine dependence. A review of the evidence. Drugs. 1983; 25:385-398. > Google Scholar37. Busto U, Sellers EM. Pharmacokinetic determinants of drug abuse and dependence. A conceptual perspective. Clin Pharmacokinet. 1986; 11:144-153. > Google Scholar38. Rosenberg HC, Chiù TH. Time course for development of benzodiazepine tolerance and physical dependence. Neurosci Biobehav Rev. 1985; 9:123-131. > Google Scholar39. Ashton H. Benzodiazepine withdrawal: an unfinished story. British Medical Journal [Clinical Research]. 1984; 25:385-398. > Google Scholar40. Ashton H. Benzodiazepine withdrawal·, outcome in 50 patients. British Journal of Addiction. 1987; 82:665-671. > Google Scholar41. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994. > Google Scholar42. Benzer DG, Smith DE, Miller NS. Detoxification from benzodiazepine use: strategies and schedules for clinical practice. Psychiatric Annals. 1995; 25:180-185. > Google Scholar43. Sedatives and antianxiety agents. In: Drug Abuse and Drug Research: The Second Triennial Report to Congress from the Secretary, Department of Health and Human Services Washington, DC: Alcohol, Drug Abuse, and Mental Health Administration; National Institute on Drug Abuse; 1987. DHHS Publication ADM 87-1486. > Google Scholar44. National household survey on drug abuse: Main findings, 1985 Washington, DC: Alcohol, Drug Abuse, and Mental Health Administration, National institute on Drug Abuse, Division of Epidemiology and Statistical Analysis; 1988. DHHS Publication ADM 88-1586. > Google Scholar45. Wolf B, Iguchi MY, Griffiths RR. Sedative/tranquilizer use and abuse in alcoholics currently in outpatient treatment: incidence, pattern and preference. In: Harris LS, ed. Problems of Drug Dependence. Washington DC: US Government Printing Office; 1990:375-376. NIDA Research Monograph No. 95, DHHS Publication ADM 90-1663. > Google Scholar46. Juergens SM, Morse RM. Alprazolam dependence in seven patients. Am J Psychiatry. 1988; 145:625-627. > Google Scholar47. Stitzer ML, Griffiths RR, McLellan AT, Grabowski J, Hawthorne JW. Diazepam use among methadone maintenance patients: patterns and dosages. Drug Alcohol Depend. 1981; 8:189-199. > Google Scholar48. Wolf B, Grohmann R, Biber D, Brenner PM, Ruther E. Benzodiazepine abuse and dependence in psychiatric inpatients. Pkarmacopsychiatry. 1989; 22:54-60. > Google Scholar49. Juergens SM. Benzodiazepines and addiction. In: Miller NS, ed. Psychiatr Clin North Am. 1993; 16:75-85. > Google Scholar50. Lader M. Dependence on benzodiazepines. J Clin Psychiatry. 1983; 44:121-127. > Google Scholar51. Lindsey DeVane C, Ware MR, Lydiard BR. Pharmacokinetics, pharmacodynamics, and treatment issues of benzodiazepines: alprazolam, adinazolam, and clonazepara. 1991; 274):463-473. > Google Scholar52. Alexander B, Perry PJ. Detoxification from benzodiazepine: schedules and strategies. J Subst Abuse Treat. 1991; 8:9-17. > Google Scholar53. Ashton H. Protracted withdrawal syndromes from benzodiazepines. J Subst Abuse Treat. 1991; 8:19-28. > Google Scholar54. Ashton H. Protracted withdrawal from benzodiazepines: the post-withdrawal syndrome. Psychiatric Annals. 25:174-179. > Google Scholar Previous article Next article FiguresReferencesRelatedDetailsCited by Vikander B, Koechling U, Borg S, Tönne U and Hiltunen A (2010) Benzodiazepine tapering: A prospective study, Nordic Journal of Psychiatry, 10.3109/08039481003624173, 64:4, (273-282), Online publication date: 1-Aug-2010. Gosselin P (2006) Apport de la thérapie cognitivo-comportementale dans le sevrage des benzodiazépines : analyse des études d'efficacité, Journal de Thérapie Comportementale et Cognitive, 10.1016/S1155-1704(06)70211-7, 16:4, (131-145), Online publication date: 1-Dec-2006. Gosselin P, Ladouceur R, Morin C, Dugas M and Baillargeon L (2004) Sevrage des benzodiazépines chez des patients souffrant du Trouble d'anxiété généralisée : efficacité d'une intervention comportementale et cognitive, Santé mentale au Québec, 10.7202/008617ar, 28:2, (59-86) Barker M, Jackson M, Greenwood K and Crowe S (2006) Cognitive effects of benzodiazepine use: a review, Australian Psychologist, 10.1080/00050060310001707217, 38:3, (202-213), Online publication date: 1-Jan-2003. van den Burg W (1998) De (in)effectiviteit van psychofarmaca, Dth, 10.1007/BF03060189, 18:1, (1-30), Online publication date: 1-Mar-1998. Shear M (1996) Treatment of panic and phobias, Current Opinion in Psychiatry, 10.1097/00001504-199603000-00005, 9:2, (121-124), Online publication date: 1-Mar-1996. Gold M, Miller N, Stennie K and Populla-Vardi C (1995) Epidemiology of Benzodiazepine Use and Dependence, Psychiatric Annals, 25:3, (146-148), Online publication date: 1-Mar-1995. Request Permissions InformationCopyright 2013, SLACK IncorporatedPDF download • 17.8 MB Published online3/01/95
Referência(s)